Skip to main content
. 2024 Dec 31;14(1):e70565. doi: 10.1002/cam4.70565

FIGURE 1.

FIGURE 1

Flowchart of patient selection. AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; DLBCL, diffuse large B‐cell lymphoma; FL, follicular lymphoma; HL, Hodgkin's lymphoma; LPL, lymphoplasmacytic lymphoma; MCL, mantle cell lymphoma; MZL, marginal zone lymphoma; PCNSL, primary central nervous system lymphoma; PD, progressive disease; PET‐CT, positron emission tomography‐computed tomography; PIOL, primary intraocular lymphoma; PR, partial remission; R‐CHOP, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone; REPOCH, rituximab, etoposide, prednisolone, doxorubicin, cyclophosphamide, and vincristine.